McArdle Trainee Seminar Series (Student/Postdoc)
This event has passed.
6571 WIMR II
BRD8 is a therapeutic bfor overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer
Ang Gao, PhD
Xu Lab